8JW-32550-39698
4 vaccinations
2 coded responses
23 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 660 / KS
- Registered
- 2021-02-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-18
Registered in v-safe
-
2021-02-18
Dose 1 — Pfizer-BioNTech
- 2021-02-18
- 2021-02-19
- 2021-02-21
- 2021-02-22
-
2021-02-25
Health check-in — day 7, dose 1Feeling: Good · Headache · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-03-04
-
2021-03-11
Dose 2 — Pfizer-BioNTech
-
2021-03-11
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-12
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-03-15
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling, Itching · NoneAdult check-in
- 2021-03-17
- 2021-03-18
- 2021-03-25
- 2021-04-03
- 2021-04-11
- 2021-04-22
- 2021-06-10
- 2021-09-09
-
2021-11-02
Dose 3 — Moderna
- 2022-03-11
-
2022-09-02
Dose 4 — Pfizer-BioNTech
- 2022-10-07
- 2022-10-14
-
2022-12-02
Survey response — 3 months, dose 4MedDRA: Mastitis — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationFree text: MastitisMedDRA releases: 2024-11 · check-in free text available
-
2022-12-02
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
-
2022-12-06
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2023-03-03
Survey response — 6 months, dose 4MedDRA: COVID-19, Cough, Streptococcal infection — Feeling: FairMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-18 | Pfizer-BioNTech | |
| 2 | 2021-03-11 | Pfizer-BioNTech | |
| 3 | 2021-11-02 | Moderna | No |
| 4 | 2022-09-02 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 12 — 3 months, dose 4
Symptoms: Mastitis
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Mastitis | · | · | ✓ |
| SD | Streptococcal infection | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release